Stock Events

Stock Events

Akero Therapeutics (AKRO) Q4 2024 Earnings

8NovConfirmed

Q4 2023

Q2 2024

Q3 2024

Q4 2024

-1.05

-0.97

-0.89

-0.81

Details

Expected EPS

-0.878678

Actual EPS

-1.05

Surprise EPS

-0.17

Surprise Percent

+19.5%

Description

Akero Therapeutics (AKRO) has reported earnings of -1.05 per share for Q4 2024.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.